Important regulatory news last week included Otsuka gaining accelerated Food and Drug Administration approval for its Voyxact (sibeprenlimab) for immunoglobulin A nephrology, India’s Sun Pharma for ...
International understanding of China’s arrival as a leading player on the world stage as an innovator of new medicines is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback